000028 国药一致
2024/06 - 中期
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额929,3782,937,1392,560,4311,655,1811,502,747
投资活动产生之现金流量净额(169,407)(135,435)(342,819)(455,532)(2,783,229)
筹资活动产生之现金流量净额(1,046,788)(2,407,642)(1,507,760)(1,871,641)(1,740,423)
汇率变动对现金及现金等价物的影响(1,224)(941)(1,190)391(53)
现金及现金等价物净增加/(减少)(288,042)393,121708,661(671,601)(3,020,958)
期初现金及现金等价物余额5,835,2945,442,1734,733,5125,405,1138,426,071
期末现金及现金等价物余额5,547,2525,835,2945,442,1734,733,5125,405,113